药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Quinidine barbiturate
Nylidrin
Nylidrin may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Seletracetam
Seletracetam may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Methsuximide
Methsuximide may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Clevidipine
Clevidipine may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Lucinactant
Lucinactant may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Nebivolol
Nebivolol may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Celiprolol
Celiprolol may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Fluspirilene
Fluspirilene may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Flunarizine
Flunarizine may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Cyclandelate
Cyclandelate may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Prenylamine
Prenylamine may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Nimesulide
Nimesulide may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Penbutolol
Penbutolol may increase the bradycardic activities of Ceritinib.
Quinidine barbiturate
Armodafinil
The metabolism of Ceritinib can be increased when combined with Armodafinil.
Quinidine barbiturate
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Ceritinib.
Quinidine barbiturate
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Ceritinib.
Potassium cation
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Cannabidiol.
Potassium cation
Satralizumab
The serum concentration of Cannabidiol can be decreased when it is combined with Satralizumab.
Potassium cation
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cannabidiol is combined with Oliceridine.
Potassium cation
Abametapir
The serum concentration of Cannabidiol can be increased when it is combined with Abametapir.